Neural stem cells (NSCs) generate neurons throughout life in the hippocampal dentate gyrus (DG). How gene expression signatures differ among NSCs and immature neurons remains largely unknown. We isolated NSCs and their progeny in the adult DG using transgenic mice expressing a GFP reporter under the control of the Sox2 promoter (labeling NSCs) and transgenic mice expressing a DsRed reporter under the control of the doublecortin (DCX) promoter (labeling immature neurons). Transcriptome analyses revealed distinct gene expression profiles between NSCs and immature neurons. Among the genes that were expressed at significantly higher levels in DG NSCs than in immature neurons was the growth factor insulin-like growth factor 2 (IGF2). We show that IGF2 selectively controls proliferation of DG NSCs in vitro and in vivo through AKT-dependent signaling. Thus, by gene expression profiling of NSCs and their progeny, we have identified IGF2 as a novel regulator of adult neurogenesis.
Introduction
A number of neuropsychiatric diseases such as epilepsy, stroke, age-related cognitive decline, and depression result in neuronal loss or dysfunction (Zhao et al., 2008) . The discovery of neural stem cells (NSCs) in the adult brain that are proliferating and able to generate functional neurons gave rise to the idea that neuronal loss could be ameliorated by harnessing endogenous NSCs for brain repair Suh et al., 2009 ). To achieve this goal, NSCs first have to be characterized in detail and their developmental programming must be better understood.
Under physiological conditions, the generation of substantial amounts of new neurons is restricted to two brain areas: the subventricular zone (SVZ) lining the lateral ventricles (Lois and Alvarez-Buylla, 1994 ) and the subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus (Kuhn et al., 1996) . NSCs of both neurogenic regions share intrinsic stem cell properties: when isolated and cultured in vitro, adult NSCs from the SVZ and DG are self-renewing, multipotent, and express several stem cell-associated proteins, such as the transcription factor SRY-box2 (SOX2) (Palmer et al., 1995; Doetsch et al., 1999; Seaberg and van der Kooy, 2002; Shi et al., 2004; Babu et al., 2007; Suh et al., 2007; Walker et al., 2008) . In addition, newborn neurons express the microtubuli-associated protein Doublecortin (DCX), which is expressed for ϳ3 weeks after cells are born, before they become functionally incorporated into the hippocampal or olfactory circuitry (van Praag et al., 2002; Carleton et al., 2003; Jessberger and Kempermann, 2003; Kempermann et al., 2004; Couillard-Despres et al., 2005) .
Over the last decade, substantial progress has been made in identifying regulators of stem cell activity and neuronal differentiation. It appears that a number of extrinsic and intrinsic factors such as Wnt, Shh, BMP, and Notch control stem cell proliferation (Lai et al., 2003; Lie et al., 2005; Breunig et al., 2007; Lugert et al., 2010; Mira et al., 2010) . Similarly, neuronal differentiation and maturation are regulated by intrinsic programs orchestrated through transcription factors such as NeuroD1 and a number of external cues, among them GABA and glutamate signaling (Ge et al., 2006; Tashiro et al., 2006; Gao et al., 2009) .
Gene expression profiling of NSCs and their neuronal progeny holds the potential of identifying novel and niche-specific regulators of neurogenesis; however, previous attempts have failed to do so, either due to the sparseness of NSCs and newborn neurons within the adult brain or because these studies have focused exclusively on NSCs or immature neuronal populations (Pennartz et al., 2004; Beckervordersandforth et al., 2010) .
In this study, we sought to identify novel regulators of adult neurogenesis by comparing gene expression profiles of discrete cell populations representing either NSCs or immature neurons. NSCs were isolated from transgenic mice expressing a GFP reporter under the control of the Sox2 promoter (hereafter called SOX2ϩ cells), and immature neurons were isolated from mice expressing a DsRed reporter under the control of the DCX promoter to isolate immature neurons (hereafter called DCXϩ cells; Couillard-Despres et al., 2006; Suh et al., 2007) . Using this approach, we identified novel and selective regulators of distinct steps in the developmental course of adult hippocampal neurogenesis, thereby providing the first gene expression-based analysis of adult hippocampal neurogenesis.
Materials and Methods
Fluorescence-activated cell sorting. Two previously described transgenic mouse lines were used for fluorescence-activated cell sorting (FACS) of SOX2ϩ and DCXϩ cells: one line expressed GFP under the Sox2 promoter and the other line expressed DsRed under the Dcx promoter (Couillard-Despres et al., 2006; Suh et al., 2007) . For each experiment, the DGs of 10 hippocampi from 6-to 8-week-old mice were dissected and pooled. Dissected tissue was chopped into ϳ1 mm 3 pieces using sterile razor blades and dissociated by incubation for 30 min in a solution containing 0.01% papain (25 U/mg, Worthington Biochemicals), 0.1% neutral protease (0.5 U/mg, Roche), and 0.01% DNaseI (2788 U/mg, Worthington Biochemicals). The cell suspension was mixed with an equal volume of DMEM:F12 media (containing 1 mM L-glutamine and 10% fetal bovine serum) and filtered through a 70 m nylon mesh, mixed with an equal amount of Percoll solution and pelleted (20,000 g for 30 min). Cellular debris was removed, and cells were spun down and dissolved in 2 ml of DMEM:F12 plus N2 supplement. For FACS, GFP was excited with a 488 nm water-cooled argon laser; DsRed was excited with a 561 nm solid-state laser. The filters used were 530/30 nm for GFP and 630/22 nm for DsRed using a BD FACSvantage Diva system (BD Biosciences). Three independent FACS experiments were performed for each cell type.
Microarray analysis. RNA from 1000 cells from each cell population was isolated with TRIzol reagent (Invitrogen), amplified and reverse transcribed using the SuperAmp protocol (Miltenyi). cDNA was hybridized on 44 K mouse whole genome arrays (Agilent). The integrity of the cDNA was validated with the Agilent 2100 Bioanalyzer. Raw Cy3 data were normalized to the median and all values that were smaller than 1 were set to zero. All genes that had zero values in at least 5 of 6 arrays were deleted from the list, leaving 29,148 genes for analysis. Data were analyzed using the CARMA software suite (https://carmaweb.genome. tugraz.at/carma/; Rainer et al., 2006) . The values were log 2 transformed and quantile normalized. Expression differences were calculated over three replicates between two groups of experiments with the LIMMA package using a modified t-statistic. The Benjamini and Hochberg false discovery rate was used to calculate p values. The final gene lists contain all genes with a p value Յ0.05. Expression values of genes that were represented more than once on the array were averaged. Heatmaps were generated using the statistics software R (R Development Core Team, 2008) using the heatmap.2 method implemented in the gplots package (www.rosettabio.com/products/ resolver). Array data are available online at the Gene Expression Omnibus (GSE21208; www.ncbi.nlm.nih.gov/geo). Gene Ontology classification and pathway analyses were performed using the MetaCore software package (www.genego.com/metacore).
Quantitative PCR. Two methods for quantitative PCR (qPCR) experiments were used: SYBR Green and TaqMan. cDNA was synthesized using the SuperAmp protocol (Miltenyi). qPCR was performed either with a Power SYBR Green PCR Master Mix on an ABI Prism 7000 Sequence Detection System (Applied Biosystems) or with a TaqMan PCR Master Mix (Applied Biosystems) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). All qPCRs were performed using the same protocol (50°C, 2 min; 95°C, 10 min for 1 cycle; 95°C, 30 s; 60°C, 1 min for 40 cycles). All qPCRs were done in biological and technical triplicates. Data were analyzed using the SDS2.1 software package (Applied Biosystems) and Microsoft Excel. GAPDH was used as an endogenous normalization control and the fold expression relative to GAPDH was determined by the ⌬⌬C t method. All primer sequences used are available upon request. We used the Student's t test to test for significance.
Cell culture and constructs. We isolated NSCs from micro-dissected DG and SVZ of 6-to 8-week-old adult mice as described previously (Ray and Gage, 2006) . shRNA oligos were cloned into the original LentiLox3.7 vector (Addgene 11795), which contains an U6-driven cloning site and a CMV-driven GFP or a modified vector containing an U6-driven cloning site and a CMV-driven mCherry. Target sequences were CCAAA-GAGCTCAAAGAGTT and GGACCGCGGCTTCTACTTCAGT (Zhu et al., 2007) . As a control, we used vectors expressing an shRNA that does not have a murine target (nontargeting shRNA, CCTAAGGTTAAGTCGC C). Coding sequences for AKT (Addgene plasmid #9021) and dominantactive AKT (AKTdPH, Addgene plasmid #9009) were cloned into retroviral vectors as described previously (Jessberger et al., 2008) . To test the efficiency of shRNAs to knockdown IGF2 protein levels, 293T cells were collected in standard RIPA buffer 48 h after transfection with Igf2-overexpressing and shRNA constructs using Lipofectamine 2000 (Invitrogen). Knockdown of IGF2 protein was analyzed by Western blots as described previously (Jessberger et al., 2008) . For rescue experiments, IGF2 (20 ng/ml, Biotrend) was added to the culture medium 1 d after lentiviral transduction for 2 d before proliferation analyses. The peptide analog of IGF-I, JB1 (Bachem Biosciences), was used to block IG1R function. JB1 (1 g/ml) was added to the culture medium 1 d after virus transduction. Two d after JB1 application, EdU was added to the culture medium for 1 h to measure proliferation rate.
For phosphoprotein Western blots, the RIPA buffer contained a mix of phosphatase inhibitors (Phosphatase Inhibitor Cocktail 1 and Phosphatase Inhibitor Cocktail 2, Sigma). Protein was isolated from mouse DG and mouse SVZ stem cell cultures either under proliferation or differentiation conditions (2 d for proliferation; 2 weeks for differentiation by growth factor withdrawal). Cells were infected with lentiviruses 1 d after plating and lysed using RIPA buffer containing protease inhibitors (Complete mini EDTA-free, Roche). Proteins were separated by SDS-PAGE on a 4 -12% Bis-Tris gradient gel (Invitrogen) and transferred to a nitrocellulose membrane (Bio-Rad). Membranes were probed overnight using mouse ␣-pAKT (Cell Signaling Technology), rabbit ␣-AKT (Cell Signaling Technology), rabbit ␣-pIRS-1 (Cell Signaling Technology), rabbit ␣-IRS-1 (Cell Signaling Technology), or goat ␣-IGF-2 (Santa Cruz Biotechnology). HRP-conjugated secondary antibodies or AP-conjugated antibodies (Promega) were used at 1:4000 dilutions. Bands were detected by enhanced chemiluminescence substrate (Millipore) or CDS-Star substrate (Roche).
The levels of IGF2 in murine NSC cultures were measured using the Mouse IGF-II DuoSet (R&D Systems) ELISA kit, according to the manufacturer's instructions. IGF2 samples were taken from mDG/mSVZ and differentiated mDG stem cell cultures. Lysates were extracted using RIPA buffer and medium was first concentrated using Amicon Ultra centrifugal filter devices (Millipore) before measurement. Serial dilutions of IGF2 standard were assayed in parallel with lysates and culture medium samples. IGF2 concentration was expressed as pg/ml lysate or culture medium. The optical density was plotted against standard IGF2 concentrations to generate the standard curve, according to the manufacturer's protocol. Samples were read at 450 nm using a SpectraMax 190 Absorbance Microplate Reader (Molecular Devices).
For proliferation experiments, cells were pulsed for 1 h with 10 M EdU (Invitrogen) and then fixed. EdU was visualized according to the manufacturer's protocol (Invitrogen) . To analyze the mode of IGF2 ac- tion, we transduced NSCs using lentiviruses expressing shRNA against Igf2 with varying virus titers, thus leading to the infection of NSC cultures in different concentrations with transduced and nontransduced cells in the same culture dish. For differentiation, growth factors were withdrawn and cells were kept in DMEM:F12 plus heparin for 14 d. For all virus-mediated Igf2 knockdown experiments in vitro, 25 fields per coverslip (n Ն 3) were imaged using a 40ϫ objective on an inverted microscope (Zeiss Axiovert Observer-D1). GFPϩ and EdUϩ cells were counted using ImageJ (colocalization and cell counter plug-ins, NIH). Approximately 2000 GFPϩ cells were counted per condition in the DG NSC proliferation assay and in the rescue experiment using 20 ng/ml IGF2 as a supplement. Approximately 1500 cells were counted for the proliferation assay of SVZ NSCs. Approximately 1000 cells per condition were analyzed for the differentiation experiments. In the rescue experiment, using a virus to overexpress AKT together with Igf2 knockdown or control viruses, ϳ400 DG NSCs were counted per condition. In the IGF1R inhibition experiment using the pharmacological inhibitor JB1 (1 g/ml), ϳ800 GFPϩ cells were counted. For the dilution series experiments, ϳ6000 DAPIϩ cells were counted per condition. GFPϩ cells were calculated by subtracting the GFPϪ cells from the total DAPIϩ cells. The GFPϩEdUϩ cells were calculated by subtracting the total GFPϪEdUϩ cells from the total EdU cell number.
Animals and immunostaining. Female mice were used for all immunohistochemical experiments: WT (C57BL/6) were 6 -8 weeks old and nestinGFP transgenic mice were 8 weeks old (Yamaguchi et al., 2000) . All protocols were approved by the Salk Institute's Institutional Animal Care and Use Committee or by the veterinary office of the Canton of Zurich. For knockdown of IGF2, animals were injected with lentiviruses (two shRNAs targeting Igf2 mRNA, one nontargeting, control shRNA) into the DG (coordinates from bregma anteroposterior (AP) Ϫ2.0, ML, Ϯ1.5, DV Ϫ2.3 from skull or for SVZ AP Ϫ1.0, ML Ϯ 1.0, DV Ϫ2.8 from skull). Three weeks after viral injections, animals received one injection of IdU (87 mg/kg bodyweight) and were killed 24 h later. Tissue was processed for immunostaining as described earlier . Briefly, brains were cut into 40-m-thick sections and distributed into 12 series. One series from each brain (n Ն 3) was stained and used for counting cell numbers. All countings were done using serial scanning microscopy. For all combinations analyzed, Ն50 cells per animal (with n Ն 3) were phenotyped for the expression of the respective markers. For intensity measurement, images were taken with a Leica SP2 confocal fluorescence microscope, using the same settings for all conditions. All sections were stained and imaged in parallel. IGF2 staining fluorescence intensity was measured and calculated using ImageJ (NIH). Immunostaining intensity was measured over the virus-infected area and normalized to the intensity of the nontargeting shRNA. Integrated density measurements of the control were set to 1.
Primary antibodies used were rat ␣-BrdU (Harlan Seralab), mouse ␣-BrdU (Becton Dickinson; for IdU detection), rabbit ␣-GFP (Invitrogen), chicken ␣-GFP (Aves Labs), rabbit ␣-SOX2 (Millipore Bioscience Research Reagents), goat ␣-SOX2 (Santa Cruz Biotechnology), goat ␣-DCX (Santa Cruz Biotechnology), rabbit ␣-DCX (Cell Signaling Technology), mouse ␣-GFAP (Millipore Bioscience Research Reagents), goat ␣-IGF2 (Santa Cruz Biotechnology), and rabbit ␣-Ki67 (Novocastra). All secondary antibodies were from Jackson ImmunoResearch. Fluorescent signals were detected using two different spectral confocal microscopes (Radiance 2100, Bio-Rad, and Leica SP2). Nuclei of cells and tissues were counterstained with 4 -6-diamidino-2-phenylindole (DAPI, Sigma). Images were processed in Adobe Photoshop (CS5 for Mac; Adobe Systems) for general contrast enhancements and color adjustments.
In situ hybridization. Single-stranded RNA probes against Igf2 mRNA were generated by in vitro transcription of a full-length Igf2 cDNA (Open Biosystems plasmid MMM1013-9201704) using T7 or Sp6 RNA polymerase in the presence of digoxigenin (DIG)-UTP. The hybridization procedure was performed according to standard procedures (Wilkinson, 1998) .
Statistical analyses. All numerical analyses were performed using Excel (Microsoft) or SPSS (IBM). Two sample t tests or ANOVA (if applicable) were used for all comparisons. Differences were considered significant at p Ͻ 0.05.
Results

FACS-based isolation and transcriptome analyses of SOX2؉ and DCX؉ cells from the adult DG
We microdissected the DG of transgenic mice that were expressing either GFP under the control of the Sox2 promoter or DsRed under the control of the Dcx promoter (Couillard-Despres et al., 2006; Suh et al., 2007) , and we subsequently performed FACS for SOX2ϩ and DCXϩ cells (Fig. 1 A, B) . We used the resultant cell populations for RNA preparation and performed microarray hybridization experiments. To identify differentially regulated genes, we used statistical analysis of microarray data (see Materials and Methods, Microarray analysis). Only genes that were found to be significant after multiple testing corrections (Benjamini and Hochberg; p Ͻ 0.05) were included in the analyses. We validated a set of differentially regulated genes with quantitative PCR (qPCR; Fig.  1C,D) . The array and qPCR expression data were in agreement for all tested genes, with a generally high concordance between fold changes calculated from the array and from qPCR analyses (data not shown). Cluster analyses of differentially expressed genes revealed the high reproducibility of the biological triplicates (Fig. 1E) .
Analyses of gene expression data showed that 1494 genes (3.4% of all transcripts interrogated) were differentially regulated between SOX2ϩ and DCXϩ cells in the DG. Of these, 840 genes (ϳ56%) were upregulated and 654 genes (ϳ44%) were downregulated in DCXϩ cells compared with SOX2ϩ cells. The top 10 regulated genes are shown in Figure 1 F. We used gene annotation analysis of gene ontology (GO) terms to identify pathways and processes of regulated genes that had a significant enrichment of regulated genes within the DG. We found that, among others, the GO classes of developmental processes and cell differentiation were significantly enriched in SOX2ϩ cells (Fig. 1G) . In DCXϩ cells, we found GO terms of genes enriched that are associated with nervous system development, neurogenesis, generation of neurons, and neurite development. Among the highly expressed genes in DCXϩ cells were previously identified regulators of differentiation such as Stathmin 1 (Stmn1), a cytosolic phosphoprotein that plays an important role in regulating microtubule dynamics in the context of mitosis as well as neuronal migration (Peschanski et al., 1993) . Another example is Prox1, which has recently been identified to be critical for neuronal differentiation of hippocampal granule cells (Lavado et al., 2010; Karalay et al., 2011) . In total, we found that ϳ31% of the genes that were expressed more highly in DCXϩ cells had been previously associated with neurogenesis or differentiation, thus supporting the validity of the gene array data. In analogy, we found that ϳ29% of all genes overexpressed in SOX2ϩ cells had been previously implicated in stem cell activity or cell proliferation.
Surprisingly, we also found many genes enriched in SOX2ϩ cells enriched in GO classes associated with generation of energy, lipid metabolism and catabolic processes, which might point toward a previously unrecognized metabolic program of DG NSCs. For example, we found 12 genes enriched in SOX2ϩ cells that were annotated in the GO term regulation of lipid metabolic process (GO 0019216), among them Bmp6, Apoe, Acacb, Igfbp7, Edf1, Irs, Lrp1, Cpt1a, Pparc1a, Acaa2, and Acsl6.
IGF2 is highly expressed in NSCs in the DG
We next sought to characterize the functional significance of a gene that is highly expressed in the SOX2ϩ cell population in the Graph shows the amount of Igf2 in the medium in pg/ml normalized to total protein (mg/ml). B, IGF2 protein levels are higher in DG-derived NSCs than in SVZderived NSCs. Total protein was isolated from proliferating NSCs isolated from DG or SVZ. Western blot analysis showed higher protein levels of IGF2 in DG-than in SVZ-derived (Figure legend continues.) DG. We focused our analyses on IGF2, which we identified to be highly expressed in SOX2ϩ cells compared with DCXϩ cells (ϳ60-fold; Fig. 2 A) . This expression profile, together with previous data showing that the growth factor IGF2 plays an important role during embryonic development and has been implicated in sonic hedgehog (Shh)-mediated cell proliferation and neuronal survival (Toretsky and Helman, 1996; Hartmann et al., 2005 ; Agis-Balboa et al., 2011), made IGF2 an intriguing candidate for a regulator of hippocampal neurogenesis. After confirming the array data by qPCR (Fig. 2 A) , we performed in situ hybridization using probes directed against Igf2 mRNA and found an enrichment of Igf2 mRNA in the SGZ, the site within the DG that harbors NSCs and immature neurons (Fig. 2 B and data not  shown) . In support of the mRNA expression, we detected high expression levels of IGF2 protein in the SGZ with higher expression in SOX2ϩ cells compared with DCXϩ cells in the DG (Fig.  2C,D) , corroborating the array-and mRNA-based Igf2 gene expression results. This finding also confirmed previous reports that showed Igf2 expression in the postnatal DG (Zhang et al., 2007) . We next characterized the expression of IGF2 in more detail based on previously described markers of NSCs in the adult DG (Seri et al., 2001; Kronenberg et al., 2003; Suh et al., 2007) . We found that IGF2 was highly expressed in radial glia-like NSCs expressing SOX2GFP, NestinGFP, or glial fibrillary acidic protein (GFAP) and that a substantial fraction of dividing (Ki67ϩ) cells colabeled with IGF2 (Fig. 2 E, F ) . Thus, the gene expression profiling strategy we used correctly identified IGF2 to be highly enriched in a NSC population within the adult DG.
IGF2 regulates proliferation of hippocampal NSCs in vitro
To test the functional importance of Igf2, we isolated NSCs from the adult DG and analyzed IGF2 protein levels in vitro. Independent array data obtained from SOX2ϩ cells from the SVZ indicated that IGF2 was only enriched in SOX2ϩ cells from the DG but not in SOX2ϩ cells isolated from the SVZ. Thus, we isolated in parallel NSCs from the adult SVZ. Confirming the gene expression profile, Western blots and ELISA showed that IGF2 protein was strongly enriched in DG-derived NSCs compared with NSCs derived from the SVZ (Fig. 3 A, B) . Further, IGF2 was substantially downregulated with differentiation of NSC cultures, as measured by total protein amount and protein levels in the supernatant by ELISA (Fig. 3 A, C) .
We next tested whether knockdown of Igf2 would affect NSC behavior in a cell type-specific manner. We transduced cells in vitro with lentiviruses expressing two different silencing shorthairpin RNAs (shRNAs) directed against Igf2 mRNA (Fig. 3D) . When we measured proliferation rates of DG-derived NSCs with 5-ethynyl-2-deoxyuridine (EdU) pulse labeling or by staining for Ki67, we found that IGF2 knockdown significantly decreased proliferation (Fig. 3E and data not shown) . Notably, Igf2 knockdown was not associated with enhanced apoptosis of NSCs in vitro, as measured by TUNEL assay (data not shown). Further, we found that reduced proliferation after Igf2 knockdown of DGderived NSCs was fully rescued by the addition of exogenous IGF2 (Fig. 3E) , whereas addition of IGF2 to control cells had only a minor effect on NSC proliferation (data not shown). As expected from the robust downregulation of IGF2 with differentiation, we did not observe an effect of IGF2 knockdown on neuronal differentiation of either DG-or SVZ-derived cells (Fig.  3F ) . However, we did not find an effect on proliferation in SVZderived NSCs after knockdown of Igf2 suggesting that production of IGF2 is only critical for SOX2ϩ NSCs derived from the adult DG (Fig. 3G) .
In conclusion, these data suggest that IGF2 plays a role in the proliferation of NSCs derived from the adult DG in vitro.
IGF2 regulates NSC proliferation via AKT signaling in a largely autocrine manner
We next sought to characterize the signaling pathways through which IGF2 might regulate proliferation of DG-derived NSCs. Pathway analyses of our gene expression profiles (data not shown) and previously published reports suggested that IGF2 might act via v-akt murine thymoma viral oncogene homolog 1 (AKT) to regulate NSC proliferation (Hartmann et al., 2005; Peltier et al., 2007) . To dissect the molecular mechanisms underlying the effects of IGF2 on stem cell behavior, we focused on the role of AKT-dependent signaling. We found that levels of phospho-AKT (pAKT) were significantly downregulated with neuronal differentiation, supporting a role for AKT signaling in NSC proliferation (Fig. 4 A) . ShRNA-mediated knockdown of Igf2 led to a reduction in insulin receptor substrate 1 (IRS1) phosphorylation, an intracellular adaptor protein that becomes phosphorylated upon IGF-receptor activation (Sun et al., 1991) , and a reduction in pAKT levels (Fig. 4 B, C) . In addition, we found that the phenotype of Igf2 knockdown (i.e., impaired proliferation) was rescued by overexpression of a dominant-active AKT (Fig. 4 D) . Together, these data suggest that IGF2 acts via AKT-dependent signaling to regulate proliferation of hippocampal NSCs.
We next analyzed whether IGF2 functions via an IGF1 receptor (IGF1R) or IGF2 receptor (IGF2R). Although most data suggest that IGF2R does not transduce a signal but rather sequesters the activity of IGF2 away from the IGF1R (for a review see Pollak, 2008) , recently published evidence has suggested that IGF2R might be able to mediate IGF2-dependent signaling . We used a IGF1R-specific blocking peptide (JB1; Pietrzkowski et al., 1992) and found that inhibition of IGF1R strongly reduced NSC proliferation, exceeding the effect of IGF2 knockdown alone (Fig. 4 E) . In addition, IGF2 knockdown did not further decrease NSC proliferation after JB1 treatment, suggesting that IGF2 functions via the IGF1R but also that additional 4 (Figure legend continued. ) cultures. C, IGF2 is downregulated with differentiation of DGderived NSCs. Shown is a representative Western blot and quantification of relative protein levels. D, DG cells were infected with lentiviruses expressing different shRNA sequences targeting Igf2 mRNA. shRNA sequences sh1 and sh2 resulted in ϳ75% and 60% decreases in IGF2 protein levels, respectively. Shown are representative Western blots with nontargeting shRNA (CON) or shRNA against Igf2. E, Knockdown of IGF2 using two independent lentiviruses expressing shRNAs (Igf2-sh1 and Igf2-sh2) targeting the murine Igf2 mRNA resulted in a robust decrease in the number of proliferating, EdU-labeled, DG-derived NSCs in vitro (top, red). Exogenous IGF2 rescued the proliferation defect caused by knockdown of endogenous IGF2 knockdown. IGF2 supplementation (20 ng/ml IGF2) rescued the proliferation phenotype (as measured by EdU incorporation, bottom, red) of IGF2 knockdown in DG-derived NSCs. Images show representative pictures of cells transduced with a lentivirus expressing nontargeting shRNA (CON, green, left) or expressing shRNA sequence 1 (Igf2-sh1) or 2 (Igf2-sh2). Arrowheads point to GFP-expressing, EdU-labeled cells. Data are presented as mean Ϯ SEM. Scale bar, 50 m. F, After transduction with viruses expressing shRNAs directed against Igf2 or nontargeting control shRNA, NSCs were differentiated for 14 d. There was no effect on the number of MAP2ab/GFPϩ cells compared with control. Shown are examples and the quantification of GFP (virus-expressing, green) and MAP2ab (red) colabeled cells in DG NSC cultures. Nuclei were counterstained with DAPI (blue). Data are presented as mean Ϯ SEM. Scale bar, 100 m. G, IGF2 knockdown did not affect the number of EdU-labeled cells in NSC cultures derived from the adult SVZ. Right, representative pictures of cells transduced with a nontargeting shRNA expressing lentivirus (CON, green, left) or expressing shRNA sequence 1 (Igf2-sh1) or 2 (Igf2-sh2) (green, middle and right). Arrowheads point toward GFP-expressing, EdU-labeled cells. Scale bar, 50 m. *p Ͻ 0.05.
growth factors (such as IGF1) may act on the IGF1R to regulate NSC proliferation.
To test whether IGF2 functions predominantly in an autocrine manner, we cocultured NSCs transduced with shRNAexpressing viruses in distinct ratios together with nontransduced cells. Notably, we found that only high ratios of IGF2-knockdown cells (Ͼ90% of all cells) affected the proliferation on nontransduced NSCs, as measured with EdU pulse labeling (Fig. 5) . In contrast, low ratios of IGF2-knockdown cells (Ͻ25% of all cells) did not show any effect on the proliferation on nontransduced NSCs (Fig. 5) . This finding suggests that IGF2 largely functions in an autocrine manner but also exerts paracrine effects to regulate hippocampal NSC proliferation.
Regulation of NSC proliferation by IGF2 in the adult brain
Next we analyzed whether the effects of IGF2 on NSCs that we observed in vitro also occurred within the adult brain. We injected shRNA-expressing lentiviruses stereotactically into the DG of adult mice and observed a significant drop in IGF2 protein levels within the adult DG (Fig. 6 A, D) . We next analyzed cell proliferation using the thymidine analog 5-iodo-2-deoxyuridine (IdU) 3 weeks after virus injections. In analogy to the in vitro experiments, we found that IGF2 knockdown reduced proliferation of hippocampal NSCs (Fig. 6B) . Corroborating the in vitro data, we found no effect of IGF2 knockdown on cell proliferation in the adult SVZ (Fig. 6C) . Together, these results suggest that IGF2 acts as a regulator of adult hippocampal neurogenesis. Furthermore, this finding highlights the usefulness of an unbiased gene expression profiling approach to reveal new molecular mechanisms underlying life-long neurogenesis in the mammalian brain.
Discussion
In this study we used reporter gene-assisted cell sorting of NSCs and immature neurons isolated from the DG, a neurogenic zone in adult mouse brain, and subsequently performed genome-wide transcriptome analysis of the different cell populations. We used the cell type-specific markers SOX2ϩ and DCXϩ to discern between NSCs and their neuronal progeny, respectively. With this approach, we identified IGF2 as a novel niche-specific regulator of neurogenesis that controls the proliferation of NSCs in the adult DG.
In addition, we identified a large number of genes that were previously implicated in stem cell maintenance, proliferative activity, or neuronal differentiation [for example: Sox9, Cheng et al., 2009 ; reversion-inducing-cysteine-rich protein with kazal motifs (Reck), Muraguchi et al., 2007; TAG-1, Furley et al., 1990 ; Smad interacting protein 1 (Sip1), Seuntjens et al., 2009] .
Although these findings validate our strategy of combining reporter-based cell isolation with microarray analysis, this approach is limited by the cell-type specificity of the markers we used. Although SOX2 expression is a hallmark of NSCs, a substantial fraction of classical astrocytes is also positive for SOX2 (Couillard-Despres et al., 2006; Suh et al., 2007) . In fact, we found that ϳ30% of all SOX2GFP-expressing cells in the DG colabeled with S100␤, which is not expressed in NSCs (data not shown). . IGF2 functions predominantly in an autocrine manner. Cocultured DG NSCs transduced with shRNA-expressing viruses (control and shRNA-expressing virus in green) were plated in three ratios (Ͼ90%, top; ϳ70%, middle; Ͻ25%, bottom) together with nontransduced DG-derived NSCs. Proliferation of transduced and nontransduced cells was measured by EdU labeling (red). High ratios of IGF2-knockdown cells (Ͼ90% of all cells) affected the proliferation rate of nontransduced cells, whereas at lower rates no differences could be detected compared with control. Arrowheads point to GFP-expressing, EdU-labeled cells. Data are presented as mean Ϯ SEM. Scale bar, 50 m. *p Ͻ 0.05. tions may have diminished or even masked some differences in gene expression that might have been found with access to perfectly homogeneous cell populations. Despite these limitations, we believe that our data represent a useful resource for identifying and functionally testing genes in novel pathways involved in neurogenesis. For example, we also found that EfnB3, one of the genes identified to be upregulated in DCXϩ cells of the DG, is functionally involved in the survival of newborn hippocampal neurons (data not shown).
Gene expression analyses identify IGF2 as a regulator of DG neurogenesis
One of the genes we found to be highly expressed in the stem cells of the DG was Igf2. IGF signaling has been shown to be involved in organ growth during embryonic development (DeChiara et al., 1990; Sim et al., 2006; Ye and D'Ercole, 2006) , and recent data suggest that IGF1 is critically involved in brain development and NSC behavior (for review, see D'Ercole and Ye, 2008) . Furthermore, IGF2 acts in concert with Shh signaling to regulate proliferation of cerebellar progenitors (Fernandez et al., 2010 ). IGF2 appears to also be important for the proliferation of medulloblastoma cells (Corcoran et al., 2008) .
Our validation experiments confirmed high levels of Igf2 mRNA and protein in the DG, and we found that proliferation of DG-derived NSCs is regulated by IGF2 via IGF1R and AKTdependent signaling. Notably, our data indicate that IGF2 is mainly produced by SOX2ϩ NSCs and largely acts in an autocrine manner. This mode of IGF2 signaling seems to be different from the second neurogenic area of the postnatal brain, where it has been recently shown that Igf2 is expressed in the choroid plexus of the lateral ventricles and that IGF2 appears to modulate embryonic neurogenesis by being diffused through the CSF and by signaling through the IGF1R on SVZ NSCs (Lehtinen et al., 2011) . Thus, it appears that the same signaling factor, IGF2, although derived from different sources (choroid plexus in the SVZ, SOX2ϩ NSCs in the DG), has similar effects on NSC proliferation upon activation of IGF1R. This hypothesis is also supported by our findings that FACS-based isolation of SOX2ϩ cells from the SVZ showed that SVZ-derived NSCs expressed very low levels of IGF2 compared with SOX2ϩ cells in the DG. Furthermore, knockdown of IGF2 in vitro or within the adult SVZ did not affect NSC proliferation.
Gene expression analyses followed by pathway mapping and our experimental data suggest that IGF2 acts via AKT signaling to regulate proliferation of DG-derived NSCs. AKT appears to be critically involved in cell survival and anti-apoptotic signaling throughout the brain (Brazil et al., 2004) . In addition, AKT has previously been implicated in precursor proliferation of adult NSCs (Peltier et al., 2007) . The molecular components downstream of AKT activation that mediate NSC proliferation in the context of IGF2 signaling remain unclear. However, it seems reasonable to speculate that AKT may serve as a hub to integrate pro-proliferative signals (such as IGF2) with pathways that induce quiescence, such as BMP or PTEN signaling (Groszer et al., 2001; Mathieu et al., 2008) . Further studies are required to understand the interplay between these signaling cascades in regulating the proliferative behavior of hippocampal NSCs.
Harnessing endogenous NSCs for brain repair
Surveying gene expression profiles of NSCs of the adult brain and their progeny is an important step in understanding the basic biology of adult neurogenesis. Notably, ongoing neurogenesis in the adult brain has been implicated in a variety of diseases, and the continuous generation of new neurons appears to play important roles for brain tissue maintenance and brain function (Scharfman and Hen, 2007; Kempermann et al., 2008; Zhao et al., 2008) . A thorough understanding of the molecular mechanisms underlying the neurogenic process in the mature brain is therefore an important prerequisite to devising strategies aimed at targeting NSCs for brain repair. Thus, the identification of mechanisms regulating the activity of NSCs in the adult brain might prove a critical step for targeted manipulation of NSC populations in certain diseases. By providing the molecular framework for a deeper understanding of neurogenesis in the adult brain, the data provided in this work will bring us closer to using adult NSCs for endogenous brain repair.
Notes
Supplemental Tables 1 and 2 for this article are available at www.files. ethz.ch/cb/tables.xls. This material has not been peer reviewed.
